Malignant hyperthermia due to anesthesia, subs encntr

This code signifies a patient's ongoing care or follow-up for malignant hyperthermia (MH) that was triggered by anesthetic agents. MH is a severe, life-threatening pharmacogenetic disorder characterized by a rapid increase in body temperature, muscle rigidity, and metabolic acidosis, occurring during or after exposure to certain anesthetics. This specific code is for encounters after the initial diagnosis and treatment of the acute event.

Use this code for subsequent visits related to monitoring, management of residual effects, or counseling for a patient who previously experienced malignant hyperthermia due to anesthesia. This includes follow-up appointments to assess organ damage, manage long-term complications, or provide genetic counseling for the patient and family. It is also appropriate for patients presenting for pre-operative evaluation after a prior MH episode.

• Assign this code for any encounter following the initial acute MH event, where the patient is receiving ongoing care or evaluation related to the condition.
• Do not use this code for the initial acute episode; a code from the T88.3XXA category would be appropriate for the initial encounter.
• Always sequence this code as a secondary diagnosis when the primary reason for the encounter is for a specific complication or other unrelated condition.